Atrys Health Appoints María del Coriseo González-Izquierdo as Independent Director

Atrys Health Appoints Coriseo González-Izquierdo as Independent Director to Strengthen Board Leadership and Corporate Governance

Atrys Health, a medical company specializing in oncology care, telediagnosis, pathology, and nuclear medicine services, has appointed Coriseo González-Izquierdo as a new independent director to its Board of Directors. The appointment is intended to strengthen the company’s leadership and corporate governance capabilities as it focuses on consolidating growth, improving profitability, and reinforcing financial discipline and operational efficiency.

González-Izquierdo joins the board through a co-option appointment, replacing Miriam González Durántez, who has resigned from her position to stand as a candidate in the upcoming general election. Atrys Health said the new appointment took effect on the day of its announcement and will be submitted for ratification at the next General Shareholders’ Meeting convened by the company.

Alongside her appointment as an independent director, González-Izquierdo has also been named Chair and member of the Appointments and Remuneration Committee. She will additionally serve as a member of the Audit Committee. These responsibilities place her in important oversight roles involving board appointments, remuneration matters, and financial and corporate governance.

The appointment brings extensive experience in public administration, international markets, corporate management, and the governing bodies of listed companies to Atrys Health. Her professional background includes senior leadership positions at the Iberian Energy Market Operator and ICEX Spain Export and Investment, as well as experience with the World Bank and Spanish Economic and Commercial Offices.

The company expects her experience to contribute to its governance framework and support its strategic priorities as it continues developing its healthcare services business.

Board Appointment Marks a New Governance Development

The appointment of González-Izquierdo represents a change in the composition of Atrys Health’s Board of Directors following the resignation of Miriam González Durántez. The outgoing director decided to leave the board to stand as a candidate in the upcoming general election.

To fill the position, the Board of Directors approved González-Izquierdo’s appointment through co-option. Under this arrangement, the board appoints a new director to fill a vacancy, subject to the applicable corporate governance procedures and subsequent shareholder consideration.

Although the appointment is effective immediately, Atrys Health will submit it for ratification at the next General Shareholders’ Meeting. This step will allow shareholders to consider the appointment as part of the company’s formal governance process.

The company has also assigned González-Izquierdo responsibilities within two key board committees. She will serve as Chair and member of the Appointments and Remuneration Committee and as a member of the Audit Committee.

These roles are relevant to the board’s oversight responsibilities. The Appointments and Remuneration Committee is associated with matters involving board composition, appointments, and remuneration policies. The Audit Committee plays an important role in overseeing financial reporting and related governance responsibilities.

By assigning González-Izquierdo positions in both committees, Atrys Health is bringing her experience into areas that are important to the company’s governance and oversight structure.

CEO Highlights Experience in Corporate Governance and International Markets

Marian Isach, CEO of Atrys Health, welcomed the appointment and highlighted the professional experience González-Izquierdo brings to the company.

According to Isach, the new independent director strengthens the board with a combination of experience serving on the governing bodies of listed companies, a substantial background in public administration, and detailed knowledge of international markets.

He also emphasized the value of her perspective as Atrys Health works to strengthen its corporate governance model and advance its business priorities.

Isach said: “The appointment of Coriseo González-Izquierdo strengthens our Board of Directors with a profile that combines solid experience on the governing bodies of listed companies, an extensive track record in public administration, and in-depth knowledge of international markets. Her vision will be particularly valuable in further strengthening our corporate governance model and supporting Atrys during a phase focused on consolidating growth, improving profitability and reinforcing financial discipline and operational efficiency.”

The CEO’s comments identify several priorities for the company. These include maintaining growth, improving profitability, strengthening financial discipline, and increasing operational efficiency.

For a healthcare company operating across specialized medical services, these priorities involve both business development and effective organizational management. Corporate governance provides a framework through which the board can oversee strategy, evaluate management performance, and monitor important business and financial matters.

González-Izquierdo’s experience across corporate leadership, public administration, and international organizations is expected to provide an additional perspective as Atrys Health continues working toward these objectives.

González-Izquierdo Expresses Commitment to Atrys Health

González-Izquierdo also commented on her appointment, describing it as an honour to join Atrys Health at an important stage in the company’s development.

She highlighted the company’s focus on growth and expressed her intention to contribute her professional experience to its future direction.

“It is an honour to join Atrys at such an important stage in its history. The company has a clear focus on growth, and I am looking forward to taking on this new role with enthusiasm and a commitment to contributing my experience to this project,” González-Izquierdo said.

Her comments reflect an intention to support the company’s development through her new responsibilities on the board and its committees.

As an independent director, she will participate in board-level discussions and oversight. Her committee appointments will also give her specific responsibilities in areas connected with appointments, remuneration, and auditing.

The combination of these roles is particularly relevant as Atrys Health works to consolidate its growth and improve its financial and operational performance.

Strong Academic Background in Law, Economics, and Public Administration

González-Izquierdo brings an academic background that combines legal, economic, and public administration expertise.

She holds degrees in Law and Economics and Business Studies from the Pontifical University of Comillas, where she completed the E-3 program. She also earned a Master’s degree in Public Administration from Harvard University, where she studied on a Fulbright scholarship.

Her education provides a foundation across several areas relevant to corporate leadership and governance. Her legal studies are connected to regulatory and institutional frameworks, while her economics and business education provides a background in financial and organizational matters.

Her postgraduate qualification in public administration adds experience in the management and operation of public institutions and policy-related environments.

In addition to her academic qualifications, González-Izquierdo has been a member of the Senior Corps of State Commercial and Economic Experts since 1995.

This professional background has given her experience in areas involving economic policy, international trade, corporate management, and public-sector institutions.

Her combination of education and professional experience is among the qualifications Atrys Health highlighted in announcing her appointment.

Senior Leadership Experience Across Major Organizations

Throughout her career, González-Izquierdo has held several senior positions across corporate and public-sector organizations.

One of her notable roles was Director of Planning and Corporate Management, serving as Chief Financial Officer, at OMIE, the Iberian Energy Market Operator.

In this position, her responsibilities were associated with planning and corporate management within an organization operating in the energy market. The experience added to her background in financial oversight and organizational management.

She also served as Chief Executive Officer of ICEX Spain Export and Investment. This role provided senior executive experience in an organization focused on supporting Spanish companies in international markets and promoting investment.

Her career also includes international experience at the World Bank and in several Spanish Economic and Commercial Offices.

These positions gave her exposure to international economic and commercial environments and contributed to her understanding of global markets and institutional relationships.

The experience is relevant to Atrys Health’s interest in strengthening its corporate governance and supporting its growth strategy. Companies operating in specialized healthcare markets must consider business performance, financial management, and the wider commercial environments in which they operate.

González-Izquierdo’s career across different institutions offers experience in managing complex organizational responsibilities and working within varied economic and institutional settings.

Extensive Experience in Corporate Governance

Corporate governance is another significant part of González-Izquierdo’s professional background.

She currently serves as an independent director at Aena and Atalaya Mining Copper. Her experience on the boards of these companies provides direct exposure to the governance responsibilities of listed businesses.

Before these appointments, she also served on the boards of several other organizations, including ICO, CESCE, CDTI, and HUNOSA.

These roles have given her experience across different corporate and institutional environments. They have also involved participation in board-level responsibilities, where directors contribute to oversight, strategic discussions, and governance processes.

For Atrys Health, this experience is particularly relevant because González-Izquierdo will join the board as an independent director while also taking on committee responsibilities.

Independent directors contribute an external perspective to board discussions and are expected to exercise independent judgment in carrying out their responsibilities. Their experience can support oversight and help boards consider business decisions from different professional and strategic viewpoints.

Her appointment as Chair and member of the Appointments and Remuneration Committee, together with her membership of the Audit Committee, will place her in two areas that are central to the company’s governance framework.

The company has identified strengthening corporate governance as one of the reasons her experience will be valuable.

Atrys Health’s Focus on Growth and Operational Performance

Atrys Health operates in specialized areas of medicine, including oncology care, telediagnosis, pathology, and nuclear medicine services. These activities place the company within a healthcare environment where medical expertise, specialized services, and operational management are important to business performance.

The company said it is currently focused on consolidating growth, improving profitability, and reinforcing financial discipline and operational efficiency.

These objectives require continued attention to the company’s governance and management structures. As organizations develop their operations, boards play an important role in overseeing strategic priorities and ensuring that management decisions are considered within an appropriate governance framework.

The appointment of González-Izquierdo adds experience in corporate finance, public administration, international markets, and board governance to Atrys Health’s leadership structure.

Her previous executive and board positions provide a range of perspectives that may support discussions about the company’s financial and operational priorities.

The appointment also strengthens the composition of the board committees responsible for appointments, remuneration, and audit-related oversight.

Next Step: Shareholder Ratification

Although González-Izquierdo’s appointment has taken effect, Atrys Health will submit the decision for ratification at the next General Shareholders’ Meeting convened by the company.

This shareholder process is the next formal step identified in the announcement. Until then, the appointment allows her to take up the responsibilities assigned by the Board of Directors, including her roles on the Appointments and Remuneration Committee and the Audit Committee.

The change follows Miriam González Durántez’s resignation, which was prompted by her decision to stand as a candidate in the upcoming general election.

With this appointment, Atrys Health has brought in a director whose career spans corporate leadership, international economic institutions, public administration, and the boards of listed companies.

The company expects her experience to contribute to its corporate governance model and support its focus on growth, profitability, financial discipline, and operational efficiency.

As Atrys Health continues developing its specialized healthcare business, the appointment marks a further step in shaping the board’s leadership and oversight capabilities.

Source link: https://www.atryshealth.com/

Newsletter Updates

Enter your email address below and subscribe to our newsletter